Singapore markets closed

Novo Nordisk A/S (0TDD.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
100.86-0.63 (-0.62%)
At close: 07:10PM GMT
Full screen
Previous close101.49
Bid0.00 x 0
Ask0.00 x 0
Day's range100.00 - 101.72
52-week range62.74 - 105.68
Avg. volume18,200
Market cap2.294B
Beta (5Y monthly)0.20
PE ratio (TTM)0.33
EPS (TTM)3.03
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    3 No-Brainer Growth Stocks to Buy in December

    Three Motley Fool contributors believe they've identified such exceptions. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer growth stocks to buy in December. David Jagielski (Eli Lilly): Eli Lilly is becoming a beast in the healthcare industry.

  • Motley Fool

    Everyone Is Talking About This Stock. Is It a Good Long-Term Option?

    Artificial intelligence has undoubtedly been the hottest investing topic on Wall Street this year. Led by such products as Wegovy, manufactured by Danish pharmaceutical giant Novo Nordisk (NYSE: NVO), the area of obesity care is garnering substantial attention. One of Novo Nordisk's strengths is its focus on diabetes and obesity care.

  • Motley Fool

    Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?

    Both of these stocks have been big winners this year. But one could be better positioned to extend that winning streak over the next decade.